Opioid use disorder during pregnancy in Tennessee: expediency vs. science

References

• Young JL, Martin PR. Treatment of opioid dependence in the setting of pregnancy. Psychiatric Clin North Am 2012;35:441–460
   PubMed Web of Science ®Google Scholar
• Bier JB, Finger AS, Bier BA, Johnson TA, Coyle MG. Growth and developmental outcome of infants with in-utero exposure to methadone vs buprenorphine. J Perinatol 2015;4:2 . Epub 2015 Apr 2
   Google Scholar
• Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000–2009. JAMA 2012;307:1934–1940
   PubMed Web of Science ®Google Scholar
• Warren M, Miller A, Traylor J, Bauer A, Patrick S. Implementation of a statewide surveillance system for Neonatal Abstinence Syndrome – Tennessee, 2013. MMWR 2015;64:125–128
   PubMed Web of Science ®Google Scholar
• Epstein RA, Bobo WV, Martin PR, Morrow JA, Wang W, Chandrasekhar R, Cooper WO. Increasing pregnancy-related use of prescribed opioid analgesics. Ann Epidemiol 2013;23:498–503
   PubMed Web of Science ®Google Scholar
• Patrick SW, Dudley J, Martin PR, Harrell FE, Warren MD, Hartmann KE, Ely EW, et al. Prescription opioid epidemic and infant outcomes: analysis of over 100,000 pregnancies. Pediatrics 2015;135:842–850
   PubMed Web of Science ®Google Scholar
• Paulozzi L, Mack K, Hockenberry J. Vital signs: variation among states in prescribing of opioid pain relievers and benzodiazepines – United States, 2012. MMWR 2014;63:563–568
   PubMed Web of Science ®Google Scholar
• Kaltenbach K, Berghella V, Finnegan L. Opioid dependence during pregnancy: effects and management. Obset Gynecol Clin North Am 1998;25:139–151
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration (SAMHSA). Medicaid coverage and financing of medications to treat alcohol and opioid use disorders. HHS Publication No. SMA-14-4854. Rockville, MD: SAMHSA; 2014
   Google Scholar
• Haegerich TM, Paulozzi LJ, Manns BJ, Jones CM. What we know, and don’t know, about the impact of state policy and systems-level interventions on prescription drug overdose. Drug Alcohol Depend 2014;145:34–47
   PubMed Web of Science ®Google Scholar
• Winklbaur B, Kopf N, Ebner N, Jung E, Thau K, Fischer G. Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependence: a knowledge synthesis for better treatment for women and neonates. Addiction 2008;103:1429–1440
   PubMed Web of Science ®Google Scholar
• Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, O’Grady KE, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. New Eng J Med 2010;363:2320–2331
   PubMed Web of Science ®Google Scholar
• Dart RC, Surratt HL, Cicero TJ, Parrino MW, Severtson SG, Bucher-Bartelson B, Green JL. Trends in opioid analgesic abuse and mortality in the United States. New Engl J Med 2015;372:241–248
   PubMed Web of Science ®Google Scholar
• Jones CM. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers – United States, 2002–2004 and 2008–2010. Drug Alcohol Depend 2013;132:95–100
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration (SAMSHA). Results from the 2010 national survey on drug use and health: summary of national findings. [NSDUH Series H-41, HHS Publication No. (SMA) 11-4658]. Rockville, MD: SAMHSA; 2011
   Google Scholar
• McGowan CC, Weinstein DD, Samenow CP, Stinnette SE, Barkanic G, Rebeiro PF, Sterling TR, et al. Drug use and receipt of highly active antiretroviral therapy among HIV-infected persons in two US clinic cohorts. PLoS One 2011;6:e18462
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). CDC grand rounds: prescription drug overdoses – a U.S. epidemic. MMWR 2012;61:10–13
   PubMedGoogle Scholar
• Kolodny A, Courtwright DT, Hwang CS, Kreiner P, Eadie JL, Clark TW, Alexander GC. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Ann Rev Public Health 2015;36:359–574
   Web of Science ®Google Scholar
• Brogly SB, Saia KA, Walley AY, Du HM, Sebastiani P. Prenatal buprenorphine versus methadone exposure and neonatal outcomes: systematic review and meta-analysis. Am J Epidemiol 2014;180:673–686
   PubMed Web of Science ®Google Scholar
• Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2014; CD002207
   PubMed Web of Science ®Google Scholar
• Meyer MC, Johnston AM, Crocker AM, Heil SH. Methadone and buprenorphine for opioid dependence during pregnancy: a retrospective cohort study. J Addiction Med 2015;9:81–86
   PubMed Web of Science ®Google Scholar
• Stöver H, Schäffer D. SMOKE IT! Promoting a change of opiate consumption pattern – from injecting to inhaling. Harm Reduct J 2014:11:18
   PubMed Web of Science ®Google Scholar
• Weiss RD, Potter JS, Fiellin DA, Byrne M, Connery HS, Dickinson W, Gardin J, et al. Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. Arch Gen Psychiatry 2011;68:1238–1246
   PubMed Web of Science ®Google Scholar
• Jones HE, Heil SH, Baewert A, Arria AM, Kaltenbach K, Martin PR, Coyle MG, et al. Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review. Addiction 2012;107:5–27
   PubMed Web of Science ®Google Scholar